MedCity News

DECEMBER 15, 2024

How top-to-bottom collaboration can alleviate hurdles and help increase equitable access to the most effective treatments for all cancer patients. The post Closing the Gap: Advancing Precision Oncology Through Education and Collaboration appeared first on MedCity News.

Education 290

Education Patients Medicine Physicians 290

PM360

JULY 21, 2022

As pharma reps’ access to physicians continues to decline, this case study examines the effectiveness of reaching physicians through other means—the EHR. Today’s physicians struggle to balance the increasing demands of patient loads, electronic health record (EHR) systems, and time spent on administrative tasks.

Physicians 52

Physicians Media Pharma sales reps Electronics 52

pharmaphorum

NOVEMBER 18, 2022

Dr John Lin, senior vice president of immune-oncology and head of bispecifics at Regeneron , said: “The collaboration will enable Regeneron and CytomX to combine our collective oncology expertise with two premier platforms […] to develop novel immunotherapies and research their potential to transform patient lives.”.

Biopharma 105

Biopharma Physicians Sales Patients 105

pharmaphorum

DECEMBER 9, 2022

Nasdaq: AUTL), a clinical-stage biopharma and a portfolio company of Syncona Ltd., has announced that the pivotal phase 2 FELIX clinical trial of obecabtagene autoleucel (obe-cel) in relapsed/refractory (r/r) adult Acute Lymphoblastic Leukaemia (ALL) patients has met its primary endpoint of overall remission rate (ORR) at interim analysis.

Food and Drug Administration 98

Food and Drug Administration Safety Biopharma Patients 98

PM360

APRIL 22, 2024

In this issue, we take a closer look on the importance of patient education to Healthcare Professionals and navigating the challenges that arise. From important changes to engaging physicians to finding out how new technologies will help address HCPs education needs, hear what our specialist had to say.

Education 59

Education Physicians Healthcare Healthcare 59

Clarify Health

MAY 19, 2020

The time-consuming and resource-intensive path from the lab bench to the patient bedside starts with drug discovery, progresses to pre-clinical and clinical research, and then enters regulatory review. Any misstep in terms of pricing, reimbursement, or marketing could mean delays in providing therapies to the patients who need them most.

Biopharma 52

Biopharma Physicians Marketing Patients 52

pharmaphorum

JANUARY 11, 2023

The research solutions cluster came second, with 15% of the total (just over $5 billion) – marked by a $300 million third round for Chinese bioinformatics firm Enzymaster – with patient solutions at 11% ($3.6 Roche tops biopharma partnering podium. billion) led by a $300 million Series E for connected kidney care specialist Somatus.

Biopharma 75

Biopharma Specialization Physicians Healthcare 75

pharmaphorum

SEPTEMBER 12, 2022

Dr Prasanth Reddy, head of oncology at LabCorp, tells us how the company works with cancer care teams, biopharma partners, and patients as an integral part of the patient journey from testing to treatment. The test is conducted in a care provider’s office or our patient service centres (PSC).

Patients 105

Patients Medicine FDA Healthcare 105

Clarivate

MAY 24, 2023

Food and Drug Administration advisory committee’s narrow 8-6 vote in favor of recommending accelerated approval for a first-in-class gene transfer therapy was welcomed by Duchenne muscular dystrophy (DMD) patients and caregivers. Most patients must use a wheelchair by the time they are in their teens.

Patients 52

Patients Food and Drug Administration Biopharma FDA 52

Pharma Marketing Network

MARCH 25, 2022

Members of a multidisciplinary care team may include physicians, nurses, pharmacists, radiologists, dieticians…the list goes on. But one key member is often omitted: the patient’s caregiver. The caregiver’s influence on the patient’s adherence, reactions to adverse effects, and treatment persistency can be a game-changer for the brand.

Pharma 98

Pharma Education Training Transportation 98

PM360

MAY 21, 2024

From connecting with patients by interactive ads to dabbling into cross-platform integration, here is what our specialists had to say. What are new and effective ways of engaging patients who are now using streaming services? Biopharma marketers are following their audiences and investment in this channel continues to increase.

Media 105

Media Healthcare Healthcare Marketing 105

Clarivate

APRIL 24, 2023

Health systems will buy or establish an insurance plan to serve as an extension of their continuum of care, a means of directing referral streams to increase revenue and securing control over clinical and formulary decisions for patients.

Healthcare 89

Healthcare Healthcare Marketing Physicians 89

Clarivate

JULY 5, 2023

and European physicians across six specialties, and global pipeline analysis curated by experts to provide insights into the evolving landscape. However, structures such as the increased reimbursement rate at 2% may cause a further bifurcation of the market, with companies going after a certain type of payer or patient.

Marketing 97

Marketing Physicians Manufacturing Competition 97

Medgadget

FEBRUARY 17, 2023

All of these systems operate under the “master-slave” concept, which involves a surgeon sitting behind a console, away from the patient, who manipulates the mechanical arms of the robot via some kind of joystick-like device. are still done in an open fashion.

Physicians 80

Physicians Engineering Leads Side effects 80

Clarivate

DECEMBER 14, 2021

As the COVID-19 pandemic continues to evolve, we are seeing substantial shifts in the way patients access healthcare and how providers deliver care. 2021 surveys of patients and physicians in the United States conducted by Clarivate show that: Much of care delivery has gone virtual. hours seeing patients.

Pharma 52

Pharma Healthcare Healthcare Physicians 52

Pharmaceutical Technology

APRIL 25, 2023

Powered by the company’s customer relationship management system, the CGT integration hub is a platform-agnostic system that aims to improve connectivity across the CGT treatment journey, enhancing the experience for patients and healthcare providers.

Customer Relationship Management 52

Customer Relationship Management Healthcare Provider Relationship management Distribution 52

The Marketing Advantage

MAY 8, 2023

May 9, 2023 Since the Orphan Drug Act was passed in 1983, the number of products being researched and approved for rare and orphan diseases has increased dramatically, offering hope and life-saving treatments for the millions of patients affected by these often under-served conditions.

Sales 52

Sales Physicians Consulting Education 52

PM360

JUNE 16, 2023

While all patient communities and advocacy groups offer patients, their families, and their caregivers support, advice, and information, rare disease patient groups can be especially tight-knit. What are some considerations or challenges that companies should not ignore when working with patients/groups?

Patients 98

Patients Pharma Education Recruitment 98

PM360

NOVEMBER 27, 2023

I recently sat down with Erica Taylor, PhD, Vice President and Chief Marketing Officer at Genentech, to talk about the future of biopharma marketing and creating more meaningful content. We’re creating a compliant engine that will help reach healthcare professionals (HCPs) and patients faster with content that resonates.

Marketing 105

Marketing Customer Relationship Management Relationship management CRM 105

Prognos Health

FEBRUARY 1, 2022

Small and midsize pharmaceutical companies have fewer resources to dedicate to key commercialization steps such as patient and physician targeting , real-world data (RWD) curation and analysis , market share calculations, patient journey evaluations , and tracking and influencing physician prescribing behavior.

Consulting 52

Consulting Physicians Pharma Biopharma 52

MedCity News

JUNE 7, 2023

On any given day there may be more pressing issues to handle, and many companies believe “it won’t happen to us” – that is, until it does happen to you, and then it’s more important than ever to be prepared and confident with your crisis communications plan.

Physicians 246

Physicians Patients Biopharma 246

pharmaphorum

OCTOBER 18, 2022

It will create a Nasdaq-listed biopharmaceutical company under the name “Oculis Holding SA”, placing Oculis in position to become a leading global ophthalmic biopharma, with product candidates to address areas of significant medical needs affecting a growing number of patient populations.

Biopharma 59

Biopharma Management Specialization Physicians 59

Clarivate

MARCH 12, 2024

For the approximately 10% of biopharma candidates that actually manage to make it to clinical trials, many fail to achieve enough revenue once they reach the market to justify the R&D effort. In fact, one-third of drugs launched over a recent 10-year period fell short of sales expectations.

Government 52

Government Marketing Physicians Biopharma 52

Clarivate

MAY 24, 2022

Recent policy and regulatory moves have begun to sketch out a framework for rare disease drug approvals in the country, but obstacles to approvals and patient access remain. Mainland China has taken significant steps toward improving access to treatment for its estimated 20 million rare disease patients in recent years. [1]

Patients 52

Patients Food and Drug Administration Marketing Pharma 52

Medgadget

MARCH 2, 2023

To make implantation of the Alpha DaRT sources easy and precise, the company developed dedicated applicators andadapted existing biopsy devices, that physicians are already acquainted with, to deliver the radioactive sources. The rest of the patients had partial responses. with ten patients to try to duplicate the results.

Manufacturing 82

Manufacturing Leads Patients Medicine 82

Pharmaceutical Technology

SEPTEMBER 8, 2022

Speciality pharmacies play a crucial role in medication dosing, disease and side effects management, and patient care. The expert services rendered by them help in improving patient outcomes, minimising costs of the healthcare system, improving medicinal adherence and persistency and saving clinicians’ time. Benefits investigation.

Specialization 45

Specialization Leads Pharma Side effects 45

Pharmaceutical Representative Training

JANUARY 29, 2025

These high prices are the result of multiple factors: theyre derived from living organisms making them sensitive and complex for both manufacturers and patients, research requires advanced technology to test for safety and effectiveness, and theyre in high demand without much competition. The Cost-Saving Alternative: What are Biosimilars?

Marketing 52

Marketing Healthcare Healthcare Physicians 52

Clarivate

OCTOBER 25, 2023

The biggest impacts are likely to be felt by patients with PDPs that use coinsurance, which most plans do for specialty drugs. Impact for patients taking the diabetes drugs and blood thinners might be less noticeable since these drugs tend to receive coverage as preferred brand tiers with copays.

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Legacy MEDSearch

MAY 19, 2023

PaceMate ® announced today its collaboration with AliveCor ® , the global leader in FDA-cleared personal electrocardiogram technology and remote patient management solutions for the cardiovascular industry. We are proud to be the pioneer in remote cardiac management.”

Healthcare Provider 52

Healthcare Provider Management Healthcare Healthcare 52

Eversana Intouch

FEBRUARY 23, 2023

Historically, the pharmaceutical industry is economically sturdy, but three things are not: patients’ household budgets, marketing department budgets, and small-company budgets. Biopharma valuations are down, especially for public and earlier-stage companies. Implications of economic volatility abound: Patients: Market access gaps.

Marketing 52

Marketing Pharma Patients Insurance 52

Eversana Intouch

FEBRUARY 23, 2023

Historically, the pharmaceutical industry is economically sturdy, but three things are not: patients’ household budgets, marketing department budgets, and small-company budgets. Biopharma valuations are down, especially for public and earlier-stage companies. Implications of economic volatility abound: Patients: Market access gaps.

Marketing 52

Marketing Pharma Patients Insurance 52

PM360

AUGUST 7, 2024

Which data points provide the most actionable insights to inform future social media, marketing, and patient education efforts? Lastly, with the pending cookie deprecation, marketers must have identity solutions ready to deploy in lieu of 1P matched HCP or patient data. Plan your tactics to address any challenges accordingly.

Media 52

Media Education Physicians Marketing 52

Clarivate

JUNE 22, 2023

RWD is a deep and wide source of information that life sciences commercial teams can use to understand challenges in the market and the patient journey. Data from medical and pharmacy claims, electronic health records and specialty datasets provides a view of hundreds of millions of patients, pharmacies, payers, HCPs, and sites of care.

Patients 52

Patients Electronics Medical Distribution 52

Clarivate

DECEMBER 6, 2022

These health systems combine multiple sites and services, and sometimes a health maintenance organization, to provide end-to-end care to patients locally or regionally. states and the United Kingdom and sees more than 35 million patient encounters per year. Beyond the biggest players, however, there are a number of IDNs that stand out.

Networking 52

Networking Healthcare Healthcare Competition 52

MedCity News

APRIL 21, 2023

The new DEA ruling is doing a disservice not only to people with OUD, but to the entire medical care system—exacerbating a condition that will most likely lead to death.

Physicians 288

Physicians Patients Leads Medical 288

PM360

JUNE 24, 2024

Patient support programs (PSPs) are meant to do just that. We asked: • What unique considerations should be taken into account when designing patient support programs (PSPs) for niche populations with rare diseases? • How can we enhance patient engagement in rare disease support programs?

Patients 118

Patients Education Healthcare Healthcare 118

MedCity News

OCTOBER 18, 2022

According to the motion, more than one third of Planned Parenthood South Atlantic’s abortion patients between July 1 and September 30, 2022 came from out of state, totalling 1,317 people. In the same time period last year, just 322 patients came from out of state for abortions.

Physicians 246

Physicians Medical Patients Biopharma 246